18 August 2021

GSK Stockmann provides legal advice to MVP Factory on a new venture studio with DB Schenker

GSK Stockmann has advised the Berlin-based start-up MVP Factory GmbH on its joint venture studio with DB Schenker which aims to help founders of logistics companies tap into new potential.

DB Schenker has launched a new unit, Schenker Ventures, to drive innovation in logistics through collaboration with entrepreneurs. Schenker Ventures has teamed up with the Berlin agency MVP Factory to launch a venture studio which combines entrepreneurial flexibility with the strength of an established global partner.

The new venture studio enables founders of logistics companies to help drive the profound transformation which is taking place in the logistics industry. While each company represents its own ideas, there is also the opportunity to draw on concepts which Schenker Ventures and MVP Factory have developed conjointly. Selected founders will receive all of the resources they need to launch a successful business, including capital, mentoring, and expertise. Schenker Ventures will also bundle and expand DB Schenker’s existing corporate venture activities and associated investments.

GSK Stockmann has provided comprehensive legal advice to MVP Factory with a team led by Thomas Derlin in Berlin. This advice covered the complex cooperation agreement with DB Schenker as well as numerous other related agreements under corporate law, transaction law, and employment law, including the negotiations with DB Schenker.
The company is a long-standing client of the firm.

Adviser MVP Factory GmbH:

GSK Stockmann: Thomas Derlin (Lead, Venture Capital/Corporate/M&A), Jörg Kahler (IP/IT), Philipp Kuhn (Employment), Martin Hossenfelder (IP/IT), Dominik Berka (Tax); Associates: Benedikt Kreuder (Venture Capital/Corporate/M&A), Nicole Deparade (Employment)

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Thomas Derlin, LL. M.

Partner*

+49 30 203907-0

thomas.derlin@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral